HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C M Zwaan Selected Research

3-methoxytyramine (methoxytyramine)

1/20183-Methoxytyramine: An independent prognostic biomarker that associates with high-risk disease and poor clinical outcome in neuroblastoma patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


C M Zwaan Research Topics

Disease

13Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2018 - 06/2004
7Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
11/2020 - 02/2003
7Leukemia
01/2018 - 09/2005
4Neoplasms (Cancer)
06/2015 - 02/2003
2Infections
11/2020 - 01/2020
2Cytopenia
05/2014 - 06/2008
1Central Nervous System Infections (Central Nervous System Infection)
01/2020
1Aspergillosis
01/2020
1Neuroblastoma
01/2018
1Nephrotic Syndrome (Syndrome, Nephrotic)
12/2017
1Philadelphia Chromosome
12/2017
1Drug-Related Side Effects and Adverse Reactions
12/2017
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
05/2014
1Mental Disorders (Mental Disorder)
07/2013
1monosomy Chromosome 7
05/2010
1Residual Neoplasm
08/2009
1Wilms Tumor (Wilm's Tumor)
08/2009
1Cushing Syndrome
08/2009
1Aplastic Anemia (Anemia, Hypoplastic)
06/2008
1Hypersensitivity (Allergy)
01/2008
1Chromosomal Instability (Chromosome Stability)
01/2008
1Acute Megakaryoblastic Leukemia (Leukemia, Megakaryocytic)
07/2007
1Down Syndrome (Down's Syndrome)
07/2007
1Anaphylaxis (Anaphylactic Shock)
06/2004
1Hypotension (Low Blood Pressure)
06/2004
1Genomic Instability
02/2003

Drug/Important Bio-Agent (IBA)

5Gemtuzumab (Mylotarg)FDA Link
01/2016 - 02/2003
3CalicheamicinsIBA
02/2012 - 02/2003
2Transcription Factors (Transcription Factor)IBA
01/2018 - 09/2005
2Biomarkers (Surrogate Marker)IBA
01/2018 - 01/2018
2Proteins (Proteins, Gene)FDA Link
01/2018 - 02/2003
2CatecholaminesIBA
01/2018 - 06/2004
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
05/2014 - 06/2008
2Core Binding Factors (Core-Binding Factor)IBA
05/2010 - 09/2005
1Ciprofloxacin (Cipro)FDA LinkGeneric
11/2020
1Bortezomib (Velcade)FDA Link
01/2020
1Voriconazole (Vfend)FDA LinkGeneric
01/2020
1liposomal amphotericin BFDA Link
01/2020
1AzolesIBA
01/2020
13-methoxytyramine (methoxytyramine)IBA
01/2018
1Pharmaceutical PreparationsIBA
01/2018
1src-Family KinasesIBA
12/2017
1Dasatinib (BMS 354825)FDA Link
12/2017
1Protein Kinase InhibitorsIBA
12/2017
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2017
1EphrinsIBA
06/2015
1EphB1 ReceptorIBA
06/2015
1Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
05/2014
1Cyclosporine (Ciclosporin)FDA LinkGeneric
05/2014
1MicroRNAs (MicroRNA)IBA
05/2014
1Telomerase (Telomerase Reverse Transcriptase)IBA
08/2013
1Aurora KinasesIBA
03/2013
1Aurora Kinase AIBA
03/2013
1Immunotoxins (Immunotoxin)IBA
02/2012
1Inotuzumab OzogamicinIBA
02/2012
1NADP (NADPH)IBA
11/2011
1Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
11/2011
1Messenger RNA (mRNA)IBA
08/2009
1Biological ProductsIBA
08/2009
1NucleophosminIBA
02/2009
1RNA (Ribonucleic Acid)IBA
06/2008
1DNA (Deoxyribonucleic Acid)IBA
01/2008
1Janus KinasesIBA
07/2007
1Methotrexate (Mexate)FDA LinkGeneric
10/2006
1tyrosine receptor (receptor, tyrosine)IBA
09/2005
1Phosphotransferases (Kinase)IBA
09/2005
1BRCA2 ProteinIBA
11/2004

Therapy/Procedure

7Therapeutics
01/2020 - 07/2005
2Drug Therapy (Chemotherapy)
01/2018 - 08/2009
1Pleurodesis
06/2014
1Catheters
06/2014
1Critical Care (Surgical Intensive Care)
06/2004